Spontaneous growth in idiopathic short stature. European Study Group
- PMID: 8976652
- PMCID: PMC1511692
- DOI: 10.1136/adc.75.3.175
Spontaneous growth in idiopathic short stature. European Study Group
Abstract
Documenting the spontaneous growth pattern of children with idiopathic short stature (ISS) should be helpful in evaluating the effects of growth promoting treatments. Growth curves for children with ISS were constructed, based on 229 untreated children (145 boys and 84 girls) from nine European countries. The children were subdivided according to target range and onset of puberty, and the growth of these subgroups was evaluated from standard deviation scores (SDS). At birth, children with ISS were already shorter than normal (means; boys -0.8 SDS, girls -1.3 SDS). Height slowly decreased from -1.7 SDS at the age of 2 years to -2.7 SDS at the age of 16 years in boys and 13 years in girls. Final height was -1.5 SDS in boys and -1.6 SDS in girls (mean (SD): boys 164.8 (6.1) cm, girls 152.7 (5.3) cm)), which was 5-6 cm below their target height. The onset of puberty was delayed (boys 13.8 (1.3) years, girls 12.9 (1.1) years). Subclassification resulted in similar growth curves. These specific growth data may be more suitable for evaluating the effects of growth promoting treatments than population based references.
Similar articles
-
Final adult height of children with idiopathic short stature: a multicenter study on GH therapy alone started during peri-puberty.BMC Pediatr. 2020 Mar 28;20(1):138. doi: 10.1186/s12887-020-02034-8. BMC Pediatr. 2020. PMID: 32222149 Free PMC article.
-
Characteristic dynamics of height and weight in preschool boys with constitutional delay of growth and puberty or hypogonadotropic hypogonadism.Clin Endocrinol (Oxf). 2019 Sep;91(3):424-431. doi: 10.1111/cen.14048. Epub 2019 Jun 26. Clin Endocrinol (Oxf). 2019. PMID: 31211864
-
Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature.Pediatr Res. 1996 Feb;39(2):295-302. doi: 10.1203/00006450-199602000-00018. Pediatr Res. 1996. PMID: 8825803 Review.
-
Does constitutional delayed puberty cause segmental disproportion and short stature?Eur J Pediatr. 1993 Apr;152(4):293-6. doi: 10.1007/BF01956736. Eur J Pediatr. 1993. PMID: 8482274
-
Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.Horm Res. 2001;55(4):161-71. doi: 10.1159/000049990. Horm Res. 2001. PMID: 11598369 Review.
Cited by
-
A Novel Method for Adult Height Prediction in Children With Idiopathic Short Stature Derived From a German-Dutch Cohort.J Endocr Soc. 2022 May 6;6(7):bvac074. doi: 10.1210/jendso/bvac074. eCollection 2022 Jul 1. J Endocr Soc. 2022. PMID: 35668996 Free PMC article.
-
Aromatase inhibitors in pediatrics.Nat Rev Endocrinol. 2011 Oct 25;8(3):135-47. doi: 10.1038/nrendo.2011.161. Nat Rev Endocrinol. 2011. PMID: 22024975 Review.
-
Growth hormone deficiency and antipituitary antibodies in a patient with common variable immunodeficiency.J Endocrinol Invest. 2009 Sep;32(8):637-40. doi: 10.1007/BF03345733. Epub 2009 May 26. J Endocrinol Invest. 2009. PMID: 19509479
-
Treatment of children and adolescents with idiopathic short stature.Nat Rev Endocrinol. 2013 Jun;9(6):325-34. doi: 10.1038/nrendo.2013.71. Epub 2013 Apr 23. Nat Rev Endocrinol. 2013. PMID: 23609338 Review.
-
The use of somatropin (recombinant growth hormone) in children of short stature.Paediatr Drugs. 2002;4(1):37-47. doi: 10.2165/00128072-200204010-00005. Paediatr Drugs. 2002. PMID: 11817985 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical